MLL
BIIB icon

Moody Lynn & Lieberson’s Biogen BIIB Stock Holding History

Moody Lynn & Lieberson’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,890
Closed -$1.64M – 224
2023
Q1 		$1.64M Sell
5,890
-145
-2% -$40.1K 0.15% 88
2022
Q4 		$1.67M Buy
+6,035
New +$1.7M 0.15% 91
2019
Q1 		– Sell
-16,075
Closed -$4.84M – 189
2018
Q4 		$4.84M Sell
16,075
-19,618
-55% -$6.26M 0.65% 47
2018
Q3 		$12.6M Buy
35,693
+13,197
+59% +$4.54M 1.34% 27
2018
Q2 		$6.53M Buy
22,496
+1,412
+7% +$397K 0.77% 42
2018
Q1 		$5.77M Sell
21,084
-15,118
-42% -$4.69M 0.7% 44
2017
Q4 		$12.8M Buy
+36,202
New +$11.6M 1.36% 28
2015
Q3 		– Sell
-15,059
Closed -$6.08M – 163
2015
Q2 		$6.08M Sell
15,059
-35,816
-70% -$14.4M 0.97% 41
2015
Q1 		$21.5M Sell
50,875
-436
-0.8% -$172K 3.43% 1
2014
Q4 		$17.4M Buy
51,311
+431
+0.8% +$139K 2.48% 7
2014
Q3 		$16.8M Buy
50,880
+380
+0.8% +$125K 2.51% 8
2014
Q2 		$15.9M Buy
50,500
+24,450
+94% +$7.36M 2.19% 6
2014
Q1 		$7.97M Buy
26,050
+1,870
+8% +$594K 1.15% 28
2013
Q4 		$6.76M Sell
24,180
-103
-0.4% -$26.6K 0.92% 43
2013
Q3 		$5.85M Buy
+24,283
New +$5.43M 0.9% 47

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Moody Lynn & Lieberson's BIIB Position: Q2 2023 in Review

Moody Lynn & Lieberson sold out of Biogen (BIIB) in Q2 2023, closing a stake of 5,890 shares — an estimated $1.64M sold.

Moody Lynn & Lieberson first reported a position in BIIB in Q3 2013 and held it in 15 quarters. The position peaked at $21.5M in Q1 2015. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Moody Lynn & Lieberson reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 5,890 Biogen shares in Q2 2023, an estimated $1.64M.
  • Moody Lynn & Lieberson first reported a position in Biogen in Q3 2013 and held it in 15 quarters.
  • Moody Lynn & Lieberson's Biogen position peaked at $21.5M in Q1 2015.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Moody Lynn & Lieberson's 13F filing for Q2 2023, filed 27 Jul 2023.